As Ocuphire Pharma Rally Gathers Steam Post-Results, What Did Investors Initially Miss?
After a Q4 beat garnered little immediate response, OCUP stock has now traded greater than 40% higher Clinical-stage ophthalmic biopharmaceutical company Ocuphire Pharma, Inc. (NASDAQ:OCUP) announced its fourth-quarter and year-end financial…